Dual roles of PARP-1 promote cancer growth and progression.
Dual roles of PARP-1 promote cancer growth and progression.
复制标题
DOI:
10.1158/2159-8290.cd-12-0120
复制
发表时间:
2012-12
期刊:
影响因子:
28.2
通讯作者:
Knudsen KE
中科院分区:
文献类型:
--
作者:
Schiewer MJ;Goodwin JF;Han S;Brenner JC;Augello MA;Dean JL;Liu F;Planck JL;Ravindranathan P;Chinnaiyan AM;McCue P;Gomella LG;Raj GV;Dicker AP;Brody JR;Pascal JM;Centenera MM;Butler LM;Tilley WD;Feng FY;Knudsen KE
Poly(ADP-ribose) polymerase-1 (PARP-1) is an abundant nuclear enzyme that modifies substrates by poly(ADP-ribose)-ylation. PARP-1 has well-described functions in DNA damage repair, and also functions as a context-specific regulator of transcription factors. Using multiple models, data demonstrate that PARP-1 elicits pro-tumorigenic effects in androgen receptor (AR)-positive prostate cancer (PCa) cells, both in the presence and absence of genotoxic insult. Mechanistically, PARP-1 is recruited to sites of AR function, therein promoting AR occupancy and AR function. It was further confirmed in genetically-defined systems that PARP-1 supports AR transcriptional function, and that in models of advanced PCa, PARP-1 enzymatic activity is enhanced, further linking PARP-1 to AR activity and disease progression. In vivo analyses demonstrate that PARP-1 activity is required for AR function in xenograft tumors, as well as tumor cell growth in vivo and generation and maintenance of castration-resistance. Finally, in a novel explant system of primary human tumors, targeting PARP-1 potently suppresses tumor cell proliferation. Collectively, these studies identify novel functions of PARP-1 in promoting disease progression, and ultimately suggest that the dual functions of PARP-1 can be targeted in human PCa to suppress tumor growth and progression to castration-resistance.